Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.

MLA

Laske, Christoph, et al. “Amyloid-β Peptides in Plasma and Cognitive Decline after 1 Year Follow-up in Alzheimer’s Disease Patients.” Journal of Alzheimer’s Disease : JAD, vol. 21, no. 4, 2010, pp. 1263–69. EBSCOhost, https://doi.org/10.3233/jad-2010-100510.

APA

Laske, C., Sopova, K., Gkotsis, C., Eschweiler, G. W., Straten, G., Gawaz, M., Leyhe, T., & Stellos, K. (2010). Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer’s disease patients. Journal of Alzheimer’s Disease : JAD, 21(4), 1263–1269. https://doi.org/10.3233/jad-2010-100510

Chicago

Laske, Christoph, Kateryna Sopova, Christos Gkotsis, Gerhard W Eschweiler, Guido Straten, Meinrad Gawaz, Thomas Leyhe, and Konstantinos Stellos. 2010. “Amyloid-β Peptides in Plasma and Cognitive Decline after 1 Year Follow-up in Alzheimer’s Disease Patients.” Journal of Alzheimer’s Disease : JAD 21 (4): 1263–69. doi:10.3233/jad-2010-100510.